BiotechTube
Home/PEP-Therapy/Hatem Azim, MD, PhD
HA

Hatem Azim, MD, PhD

Chief Medical Officer

PEP-Therapy

Therapeutic Areas

Oncology

PEP-Therapy Pipeline

DrugIndicationPhase
PEP-010Recurrent and/or metastatic solid tumors (including pancreatic cancer)Phase 1a/b

Leadership Team at PEP-Therapy

AP
Antoine Prestat
Co-founder and CEO
JS
Jennifer Sengenès, PhD
Head of Strategy and Development
LD
Laura Dadon, PharmD
Head of Drug Development
DG
Diego Germini, PhD
Head of Research
View full PEP-Therapy profile